SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-18-014936
Filing Date
2018-12-07
Accepted
2018-12-07 17:13:51
Documents
1
Period of Report
2018-12-07
Items
Item 1.01: Entry into a Material Definitive Agreement

Document Format Files

Seq Description Document Type Size
1 8-K a8-kgel2ndamendtoassetpurc.htm 8-K 23980
  Complete submission text file 0001628280-18-014936.txt   25014
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

IRS No.: 000000000
Type: 8-K | Act: 34 | File No.: 001-33637 | Film No.: 181224200
SIC: 2834 Pharmaceutical Preparations